Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Changes in the regional homogeneity of resting-state magnetic resonance imaging in perimenopausal women

BMC Women's Health volume 21, Article number: 39 (2021) Cite this article

Abstract

Background

There is a noticeable lack of systematic researches on evaluating the correlation between serum estrogen levels and changes in brain functional areas of perimenopausal women.The aim of this study is to investigate the regional spontaneous brain activity changes in perimenopausal women.

Methods

Based on the resting-state functional magnetic resonance imaging datasets acquired from 25 perimenopausal women and 20 healthy women of reproductive age, a two-sample t-test was performed on individual normalized regional homogeneity (ReHo) maps. Relationships between abnormal ReHo values and the self-rating anxiety scale (SAS), the self-rating depression scale (SDS) were investigated with Pearson correlation analysis. We also investigated the correlation between abnormal ReHo values and serum estrogen level.

Results

In the perimenopausal group, we found increased ReHo in the right posterior cerebellum (region 2), left middle frontal gyrus and left middle cingulate gyrus (\(P<0.05\)). Additionally, the ReHo values in left middle frontal gyrus and leftt middle cingulate gyrus showed positively significant correlation with the SAS, SDS scores. On the contrary, there was no significant correlation between the ReHo value in right posterior cerebellum and SDS, SAS scores. In the perimenopausal group, the ReHo values in the left middle frontal gyrus and left middle cingulate gyrus were negatively correlated with the serum estrogen level (\(P<0.05\)).

Conclusion

The results of this preliminary study have suggested that abnormal spontaneous activities of multiple brain regions during resting state was already altered in perimenopausal women. Alterative activities might be related to emotional regulation deficits and cognitive impairment, and might potentially represent the neural mechanism underlying perimenopausal period.

Peer Review reports

Background

Perimenopause is defined as the transition of women from normal menstruation to amenorrhea, which marked by irregular menstruous cycles and fluctuations in ovarian hormones. It is a transitional state of nervous system, including disorders of the estrogen regulatory system, such as temperature regulation, circadian rhythm changes, vasomotor symptoms and sleep disturbances, which are recognized to be factors of impairing cognitive function and mood [1]. The risk of mood disorders with a key stage of psychological disorders such as depression and anxiety has been increased in perimenopausal women, and it is a critical period for women to develop Alzheimer’s disease [2]. Estrogen, regarded as the “master regulator” of a woman’s brain and body’s metabolic system, regulate glucose transport, aerobic glycolysis and mitochondrial function to generate ATP [3]. It gradually decreased with the prolongation of perimenopause. Emotional instability and cognitive impairment may be associate with such hormonal imbalances [4, 5], which can also lead to functional or structural changes in certain brain regions. However,to the best of our knowledge, there is a noticeable lack of systematic researches on evaluating the correlation between serum estrogen levels and changes in brain functional areas of perimenopausal women.

The frontal cortex and posterior cingulate cortex showed consistent biomarker abnormalities in peri- and postmenopausal women [6]. Lu et al. found that the gray matter volume in multiple brain regions of perimenopausal women decreased [7]. However, previous studies of perimenopausal women mainly focused on the changes in brain structure and morphology, not yet revealed the overall changes in the spontaneous activity of whole brain,which did not point out abnormal area of the brain accurately. In this prospective study, we hypothesized that the spontaneous neural activity of the whole brain would change in perimenopausal women. To testify this hypothesis, we (1) characterized and compared the ReHo [8] based on rs-fMRI between perimenopausal and normal reproductive age women to investigate altered spontaneous regional brain activity in perimenopausal women; (2) examined the psychological status and serum estrogen levels of perimenopausal women, with further discussing the correlation between spontaneous brain activity changes in each region and estrogen levels and psychological status, which will be helpful to yield a more comprehensive understanding of pathophysiological changes in perimenopausal women.

Methods

Subjects

The study was approved by the ethics review committee of the second affiliated hospital of shandong first medical university. Informed written consent was obtained from each participant. The subjects who met the inclusion criteria in this study were recruited from June 2017 to September 2019 at the surrounding community by posting recruitment notice.

The perimenopausal group inclusion criteria: (1) a diagnosis of perimenopause based on the Stages of Reproductive Aging Workshop (STRAW) + 10: consecutive menstrual cycle differences greater than 7 days or the occurrence of amenorrhea of 60 days or longer [9]; (2) female, right handed, age ranges from 45 to 54 years old; (3) have a uterus and at least one ovary; (4) have no diabetes, vascular diseases, hypertension and smoke history; (5) no fMRI scan contraindications, such as pacemakers, metal dentures or orthodontics. Exclusion criteria: (1) severe psychiatric disorders, such as dementia, episode, epilepsy, major depression; (2) significant neurological illness, such as significant head trauma, tumor,meningitis or central nervous system (CNS) inflammatory lesions and vascular complications clues; (3) surgical menopause such as history of hysterectomy, bilateral ovariectomy, genital tumors and vaginal bleeding of unknown etiology; (4) aphasia, deafness and blindness and others unable to cooperate with the examination; (5) centrally acting medications, intermittent estrogen or phytoestrogen supplements. People with one of the above conditions will be excluded from this experiment.

Finally, twenty five perimenopause women with ages range from 45 to 52 years (mean age 50.76 years, SD = 2.72 years) were enrolled as the perimenopausal group. In addition, we also recruited twenty reproductive subjects from 32 to 45 years (mean age 36.7 years, S.D = 8.29 years) with regular menstrual cycles at the surrounding community as the control group,who were matched in education and hand dominant with perimenopausal group.

General information and psychological assessment

The subjects’ age, age at menarche, estrogen (E2) level and education level were collected. Before undergoing the MRI, the Self-rating Anxiety Scale (SAS) [10] and the Self-rating Depression Scale (SDS) [11] scores were also gotten from each subject to assess them levels of anxiety and depression. SAS and SDS each have 20 items.Each item is scored on a scale of 1–4 (a little of the time, some of the time, a good part of the time,most of the time), and the total score ranges from 20 to 80. The raw score is then converted to an index score by dividing the raw score by the maximum score (80) and either expressing this as a decimal or multiplyingby 100 to express it as a whole number with an index score range of 25 to 100. The criteria for classifying anxiety and depression are the same. The severity of anxiety or depression was further classified as: (1) 50–59, mild; (2) 60–69, moderate; and (3) 70–100, severe [12, 13].

Venipuncture was scheduled between 8:00 and 10:00 AM after a 12-h fast during the early follicular phase(cycle days 2–5, termed “in window”) of all subjects. If a blood sample could not be obtained in the d2–5 window in the 60d after the visit date(usually because of irregular menstrual cycles), blood was obtained in the subsequent 30d without respect to menstrual bleeding. Serum was analyzed for E2. The ADVIA Centaur estradiol test was performed using an automated chemiluminescence immunoassay analyzer (Siemens Healthcare Diagnostics Inc, New York, USA). Reference standard: Early follicular phase of premenopausal women, estradiol reference range: 19.5–144.2 pg/mL.

MRI data acquisition

The MRI data were acquired using a 3.0T MR imager (Discovery MR750, GE Healthcare, Milwaukee, WI, USA). For both the perimenopausal and the control group, data were all collected at days 1–3 after onset of menses.Each subject was supine with the head snugly secured using a belt and foam pads. First, routine sequence scanning was performed to exclude brain tumors, cerebral infarction, cerebral hemorrhage and other brain abnormalities.Then the BOLD signal was sequenced with a 3D-T1 BRAVO anatomical image of the entire brain structure and an EPI gradient plane echo sequence. During rs-fMRI, subjects were asked to lie with their eyes closed, not to fall asleep,and not to think of anything in particular. The rsfMRI acquisition parameters were as follows: 3D-T1 BRAVO sequence: TE = 3.2 ms, TR = 8.2 ms, TI = 450 ms, FOV = 25.6 mm 25.6 mm, matrix = 256256, layer spacing = 0 mm, layer thickness = 1 mm, layer number = 176, NEX = 1; BOLD sequence: EPI-GRE: TR = 2000 ms, TE = 20 ms, layer thickness = 3.2 mm, layer interval = 0 mm, FOV = 22 mm 22 mm, matrix= 6464, 240 time points, 41 layers.

Data processing and ReHo calculations

Image preprocessing was performed using the data processing assistant in the rs-fMRI (DPABI) toolbox (http://rfmri.org/dpabi v3.0_171210) [14]. For each participant, the first 10 time points were discarded because of transient signal changes before magnetization reaching a steady-state and participants adapting to the fMRI noise. In order to minimize the influence of head motion, we first eliminated the subjects with more than 1.5 mm maximum displacement in any dimension and 1.5 degrees of angular motion during the entire fMRI.We then compared the motion courses of the two groups using a two-sample t-test and confirmed no statistical significance. Finally, we setted the head-motion measures and age as covariates for group-level comparisons,no subject was eliminated in this step. Then, the corrected images were spatially normalized to the Montreal Neurological Institute (MNI) EPI template in SPM8 and resampled to 3mm3mm3mm voxels, and the linear drift was removed. Individual ReHo maps were generated by calculating the Kendall’s coeffificient of concordance (KCC) of the time series of a given voxel to its nearest 26 voxels [8]. The average ReHo values of all voxels in the significant region were extracted using the rs-fMRI data analysis tool (REST, http://www.restfmri.net) [15] in the mask generated by the standardized step. Then, the resulting data were spatially smoothed with a Gaussian kernel (full-width at half-maximum [FWHM] = 6 mm).

Statistical analyses

SPSS Statistics version 20.0 was used for statistical analysis.Quantitative parameters are expressed as the meansstandard deviation.Data were tested for normality analysis using the Kolmogorov–Smirnov test and then with the Levene test for variance homogeneity analysis.Two-sample t-test was performed to assess the differences in age, age at menarche, level of estrogen, duration of education, SAS and SDS scores between the perimenopausal and control subjects.To explore the ReHo differences between the perimenopausal and control subjects, a two-sample t-test was performed on the individual normalized ReHo maps,corrected for permutation testing with Threshold-Free Cluster Enhancement (TFCE) [16]. Spearman correlation analysis was performed between the mean ReHo values in significantly different areas and the SAS, SDS scores and the estrogen levels. P values of less than 0.05 were considered as statistically significant.

Results

Demographic and clinical characteristics

Compared with the control group, the perimenopausal group had lower estrogen level (\(P=0.00\)) and higher SAS (\(P=0.00\)) and SDS (\(P=0.00\)) scores.However, there were no statistically significant differences of age at menarche (\(P=0.65\)) and education level (\(P =0.39\)), as shown in Table 1.

Table 1 Demographic and clinical characteristics of perimenopausal and control group
Full size table

Regional spontaneous activity changes

The rs-fMRI analysis showed that the ReHo values in the right posterior cerebellum (region 2), left middle frontal gyrus and left middle cingulate gyrus of perimenopausal women were higher than these in control subjects, with statistically significant differences (\(P < 0.05\)), as shown in Fig. 1 and Table 2.

Table 2 Brain regions with abnormal ReHo in perimenopausal group
Full size table
Fig. 1
figure 1

Statistically significant differences between the perimenopausal and control subjects are shown in a ReHo map of the whole-brain with MRI. The perimenopausal subjects showed a significant ReHo increase in the right posterior cerebellum (region 2), left middle frontal gyrus and left middle cingulate gyrus.A T-score bar is shown on the right. Red and green denote increases and decreases in ReHo, respectively

Full size image

Correlation between ReHo values in abnormal regions and SAS, SDS scores

There was no significant correlation between ReHo value in right posterior cerebellum and SDS and SAS scores. The ReHo value in left middle frontal gyrus was positively correlated with SDS score (\(r=0.393, P=0.029\)) and SAS score (\(r=0.377, P=0.013\)). The ReHo value in left middle cingulate gyrus was positively correlated with SDS score (\(r=0.312, P=0.016\)) and SAS score (\(r=0.303, P=0.021\)).

Correlation between ReHo value in abnormal regions and estrogen level

In the perimenopausal group, the ReHo values in left middle frontal gyrus (\(r= -0.556, P=0.025\)) and left middle cingulate gyrus (\(r=-0.489, P=0.038\)) were negatively correlated with serum estrogen levels, as shown in Figs. 2 and 3.

Fig. 2
figure 2

Correlation between ReHo value in left middle frontal gyrus and estrogen level (a on the left and b on the right). The ReHo value in left middle frontal gyrus was negatively correlated with estrogen level (\(r=-0.556\), \(P=0.025\))

Full size image
Fig. 3
figure 3

Correlation between ReHo value in left middle cingulate and estrogen level (a on the left and b on the right). The ReHo value in left middle cingulate gyrus was negatively correlated with estrogen level (\(r=-0.489, P=0.038\))

Full size image

Discussion

In the present study, resting-state functional magnetic resonance imaging (rs-fMRI) ReHo analysis, basing on blood oxygen level dependency (BOLD), was applied to investigate alterations of the resting state brain activities in perimenopausal group. It was proved that the ReHo values in the right posterior cerebellum (region 2), left middle frontal gyrus and left middle cingulate gyrus of perimenopausal women were higher than these in control subjects. Additionally, the ReHo values in left middle frontal gyrus and left middle cingulate gyrus showed positively significant correlation with the SAS, SDS scores. In the perimenopausal group, the ReHo values in the left middle frontal gyrus and left middle cingulate gyrus were negatively correlated with the serum estrogen levels.

The frontal lobe is the anatomical basis of emotional activities, attention, memory, abstraction and spatial discrimination,which is involved in the formation and consolidation of memory (instantaneous memory, short-term memory and long-term memory) and is the highest nerve center of human [17, 18]. According to a review regarding attention reorienting [19], the middle frontal gyrus linked the ventral attention network (responsible for sensory-driven exogenous attention) and the dorsal attention network (responsible for goal-directed endogenous attention), thus modulated the cognitive shift between internal and external environments. Berent [20] reported that prefrontal cortex was closely related to verbal working memory, visual working memory and cognitive impairment in menopausal women. This study demonstrated that the ReHo in the left middle frontal gyrus was increased in the perimenopausal group, suggesting a decrease in the presence of cognitive function in women at the perimenopausal stage, which was consistent with weber’s finding [21]. Furthermore, Song [22]found that increased ReHo in the middle frontal gyrus (MFG) in major depressive disorder patients.Wang [23] confirmed that hyperactivation of dorsolateral prefrontal cortex in patients with generalized anxiety disorder(GAD). It suggested that the frontal lobe is related to depression and anxiety according to the above previous analysis. In this study, we found that the increase of ReHo in left middle frontal gyrus of perimenopausal women was associated with SAS, SDS scores, and further confirmed that the middle frontal gyrus was strongly associated with negative emotional activity and cognitive changes. Therefore, we speculated that the increased ReHo in left middle frontal gyrus may be associated with abnormal feelings and emotional activity, such as misgivings of the changes in menstrual cycle.

In addition, we discovered abnormity also occurred in the left middle cingulate gyrus of perimenopausal group. As an important region of the limbic system, cingulate cortex encompassed numerous and specialized subdivisions that subserved a vast array of cognitive, emotional, motor, nociceptive and visuospatial functions [24]. It also maintained strong reciprocal interconnections with lateral prefrontal cortex (BA 46/9), parietal cortex (BA 7), premotor and supplementary motor areas, and mainly served to regulate both cognitive and emotional processing [25, 26]. In the study, we had substantiated the ReHo in the left middle cingulate gyrus was increased in the perimenopausal group, suggesting that perimenopausal women have some difficulties in regulating cognitive and emotional processing. Mataix-cols et al. found that cingulate gyrus was activated in fMRI of obsessive-compulsive disorder patients after picture and sound stimulation [27]. Another study by Wang et al. also showed that the ReHo in cingulate gyrus increased in patients with primary insomnia [28]. These above studies indicated that the cingulate gyrus was associated with cognition and emotion. It was also observed in this study that abnormal ReHo value in the left middle cingulate gyrus showed a positively significant correlation with the SAS, SDS scores, that further confirmed the importance of the cingulate gyrus in cognitive and emotional processing. We boldly speculated that the ReHo in the left middle cingulate gyrus was increased due to the increasement of ReHo in the left middle frontal gyrus,because the cingulate gyrus was strong reciprocal interconnections with the lateral prefrontal cortex.

In the present study, we discovered abnormities also occurred in the right posterior cerebellum (region 2) of perimenopausal group. It is well known that cerebellum plays an important role in the execution and planning of movement [29, 30]. Nevertheless, several studies had shown that cerebellum was also involved in some of cognitive functions, such as attention and emotion processing [31, 32]. Cerebellar dysfunction, especially the posterior lobes of cerebellum, has been implicated in many rs-fMRI studies of depression [33,34,35,36], which was consistent with our study.Therefore, we hold that increased ReHo in the right posterior cerebellum (region 2) may be the important factors and early indicators of perimenopausal cognitive deficits and affective disorders.Interestingly,for perimenopausal group, increased ReHo value of cerebellum showed no significant correlation with SAS and SDS scores in the follow-up research. We speculated that the cerebellum did not participate in affecting disturbed cognitive function directly, but played a role in complex connectivity with multiple subcortical structures [37], which is called “the cerebro-cerebellar circuit”.

In addition,previous studies have suggested that a series of abnormal emotional symptoms and cognitive impairment were related to estrogen significantly in middle-aged and elderly women, and the prefrontal cortex which served episodic and working memory were riched in estrogen receptors [38]. An interventional study involving in early postmenopausal women, suggested that the effect of estrogen on serotoninergic function may be a key mechanism related to symptoms of emotion and cognition during the menopausal transition [39]. In terms of cognitive outcomes, some evidences supported the “critical window hypothesis”, which suggested that women in the earlier stages of the menopausal transition might gain cognitive benefits from hormone therapy [40]. Although there were several studies that have showed significant effects of estrogen on the prefrontal cortex (PFC), especially in terms of concentration and working memory, no study aim to explore specific action sites of perimenopausal estrogen in PFC regions, which included multiple brain regions (Brodmann’s areas 8, 9, 10, 11, 44, 45, 46, and 47,48). In the present study, we found that the increase of ReHo in left middle frontal gyrus was negatively correlated with serum estrogen levels. So it was speculated that the fluctuation of estrogen levels had the most significant effect on the frontal middle gyrus during the perimenopausal period, and the abnormal middle frontal gyrus may be an important factor leading to perimenopausal cognitive impairment. In addition, we found that the increase of ReHo in cingulate gyrus was negatively correlated with estrogen levels, considering that fluctuations in estrogen levels led to activation of 5-HT function in the cingulate cortex [41].

Limitations

This study has some limitations. Firstly,the present study was limited by a relatively small sample size. Therefore, the results of the current study should be replicated with a larger sample. Secondly, according to Stages of Reproductive Aging Workshop (STRAW) criteria, it is divided into the early menopause transition (menstrual cycle length varying \(>7\) days in consecutive cycles) and late menopause transition (occurrence of amenorrhea of 60 days or longer) as well as partial early postmenopause [9], as estrogen levels vary with the duration of perimenopause. Thirdly, at the current stage of the study, we directly compared subjects with un-matched age in perimenopausal women and healthy women of reproductive age. Further study of matched age in perimenopausal women with different levels of estrogen may help to exclude the confunding factor that possiblely from aging effect.

Conclusion

The results of this preliminary study suggested that activity of multiple brain regions during resting state was already altered in perimenopausal women, which may be related to emotional regulation deficits and cognitive impairment,and may potentially represent the neural mechanism underlying perimenopausal period.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

rs-fMRI:

Resting-state functional magnetic resonance imaging

ReHo:

Regional homogeneity

SAS:

Self-rating anxiety scale

SDS:

The self-rating depression scale

CNS:

Central nervous system

BOLD:

Blood oxygen level dependency

MFG:

Middle frontal gyrus

GAD:

Generalized anxiety disorder

PFC:

Prefrontal cortex

References

  1. Gava G, Orsili I, Alvisi S, Mancini I, Seracchioli R, Meriggiola MC. Cognition, mood and sleep in menopausal transition: the role of menopause hormone therapy. Medicina. 2019;55(10):668.

    Article  PubMed Central  Google Scholar 

  2. Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11(7):393–405.

    Article  CAS  PubMed  Google Scholar 

  3. Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8–30.

    Article  CAS  PubMed  Google Scholar 

  4. Joffe H, de Wit A, Coborn J, Crawford S, Freeman M, Wiley A, Athappilly G, Kim S, Sullivan KA, Cohen LS, et al. Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. J Clin Endocrinol Metab. 2020;105(3):642–50.

    Article  Google Scholar 

  5. Greendale GA, Derby CA, Maki PM. Perimenopause and cognition. Obstet Gynecol Clin. 2011;38(3):519–35.

    Article  Google Scholar 

  6. Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS, et al. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Neurology. 2017;89(13):1382–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lu W, Guo W, Hou K, Zhao H, Shi L, Dong K, Qiu J. Grey matter differences associated with age and sex hormone levels between premenopausal and perimenopausal women: a voxel-based morphometry study. J Neuroendocrinol. 2018;30(12):12655.

    Article  CAS  Google Scholar 

  8. Zang Y, Jiang T, Lu Y, He Y, Tian L. Regional homogeneity approach to FMRI data analysis. Neuroimage. 2004;22(1):394–400.

    Article  PubMed  Google Scholar 

  9. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, De Villiers TJ, Group SC. Executive summary of the stages of reproductive aging workshop+ 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371–9.

    Article  CAS  PubMed  Google Scholar 

  11. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63–70.

    Article  CAS  PubMed  Google Scholar 

  12. Gainotti G, Cianchetti C, Taramelli M, Tiacci C. The guided self-rating anxiety-depression scale for use in clinical psychopharmacology. Activitas Nervosa Superior. 1972;14(1):49–51.

    CAS  PubMed  Google Scholar 

  13. Zung WW. The measurement of affects: depression and anxiety. Mod Probl Pharmacopsychiatry. 1974;7:170–88.

    Article  CAS  PubMed  Google Scholar 

  14. Yan C-G, Wang X-D, Zuo X-N, Zang Y-F. Dpabi: data processing & analysis for (resting-state) brain imaging. Neuroinformatics. 2016;14(3):339–51.

    Article  PubMed  Google Scholar 

  15. Song X-W, Dong Z-Y, Long X-Y, Li S-F, Zuo X-N, Zhu C-Z, He Y, Yan C-G, Zang Y-F. Rest: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS ONE. 2011;6(9):25031.

    Article  CAS  Google Scholar 

  16. Chen X, Lu B, Yan C-G. Reproducibility of R-FMRI metrics on the impact of different strategies for multiple comparison correction and sample sizes. Hum Brain Mapp. 2018;39(1):300–18.

    Article  PubMed  Google Scholar 

  17. Bandettini PA, Jesmanowicz A, Wong EC, Hyde JS. Processing strategies for time-course data sets in functional MRI of the human brain. Magn Reson Med. 1993;30(2):161–73.

    Article  CAS  PubMed  Google Scholar 

  18. Biswal B, Zerrin Yetkin F, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med. 1995;34(4):537–41.

    Article  CAS  PubMed  Google Scholar 

  19. Corbetta M, Patel G, Shulman GL. The reorienting system of the human brain: from environment to theory of mind. Neuron. 2008;58(3):306–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Berent-Spillson A, Briceno E, Pinsky A, Simmen A, Persad CC, Zubieta J-K, Smith YR. Distinct cognitive effects of estrogen and progesterone in menopausal women. Psychoneuroendocrinology. 2015;59:25–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Weber M, Mapstone M. Memory complaints and memory performance in the menopausal transition. Menopause. 2009;16(4):694–700.

    Article  PubMed  Google Scholar 

  22. Xue S, Wang X, Wang W, Liu J, Qiu J. Frequency-dependent alterations in regional homogeneity in major depression. Behav Brain Res. 2016;306:13–9.

    Article  PubMed  Google Scholar 

  23. Wang W, Hou J, Qian S, Liu K, Li B, Li M, Peng Z, Xin K, Sun G. Aberrant regional neural fluctuations and functional connectivity in generalized anxiety disorder revealed by resting-state functional magnetic resonance imaging. Neurosci Lett. 2016;624:78–84.

    Article  CAS  PubMed  Google Scholar 

  24. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2(6):435–43.

    CAS  PubMed  Google Scholar 

  25. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain. 1995;118(1):279–306.

    Article  PubMed  Google Scholar 

  26. Whalen PJ, Bush G, McNally RJ, Wilhelm S, McInerney SC, Jenike MA, Rauch SL. The emotional counting stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry. 1998;44(12):1219–28.

    Article  CAS  PubMed  Google Scholar 

  27. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptomdimensions in obsessive–compulsive disorder. Arch Gener Psychiatry. 2004;61(6):564–76.

    Article  Google Scholar 

  28. Wang T, Li S, Jiang G, Lin C, Li M, Ma X, Zhan W, Fang J, Li L, Li C, et al. Regional homogeneity changes in patients with primary insomnia. Eur Radiol. 2016;26(5):1292–300.

    Article  PubMed  Google Scholar 

  29. Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron. 2013;80(3):807–15.

    Article  CAS  PubMed  Google Scholar 

  30. Buckne RL, Krienen FM, Castellanos A, et al. The organization of the human cerebellum estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106(5):2322–45.

    Article  Google Scholar 

  31. Leiner HC. Solving the mystery of the human cerebellum. Neuropsychol Rev. 2010;20(3):229–35.

    Article  PubMed  Google Scholar 

  32. Schmahmann JD. The role of the cerebellum in cognition and emotion: personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev. 2010;20(3):236–60.

    Article  PubMed  Google Scholar 

  33. Dichter GS, Gibbs D, Smoski MJ. A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. J Affect Disord. 2015;172:8–17.

    Article  PubMed  Google Scholar 

  34. Lai C-H, Wu Y-T. The alterations in regional homogeneity of parieto-cingulate and temporo-cerebellum regions of first-episode medication-Naive depression patients. Brain Imaging Behav. 2016;10(1):187–94.

    Article  PubMed  Google Scholar 

  35. Wu H, Sun H, Xu J, Wu Y, Wang C, Xiao J, She S, Huang J, Zou W, Peng H, et al. Changed hub and corresponding functional connectivity of subgenual anterior cingulate cortex in major depressive disorder. Front Neuroanat. 2016;10:120.

    PubMed  PubMed Central  Google Scholar 

  36. Sun H, Luo L, Yuan X, Zhang L, He Y, Yao S, Wang J, Xiao J. Regional homogeneity and functional connectivity patterns in major depressive disorder, cognitive vulnerability to depression and healthy subjects. J Affect Disord. 2018;235:229–35.

    Article  PubMed  Google Scholar 

  37. Adamaszek M, D’Agata F, Ferrucci R, Habas C, Keulen S, Kirkby K, Leggio M, Mariën P, Molinari M, Moulton E, et al. Consensus paper: cerebellum and emotion. The Cerebellum. 2017;16(2):552–76.

    Article  CAS  PubMed  Google Scholar 

  38. McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001;91(6):2785–801.

    Article  CAS  PubMed  Google Scholar 

  39. Amin Z, Gueorguieva R, Cappiello A, Czarkowski KA, Stiklus S, Anderson GM, Naftolin F, Epperson CN. Estradiol and tryptophan depletion interact to modulate cognition in menopausal women. Neuropsychopharmacology. 2006;31(11):2489–97.

    Article  CAS  PubMed  Google Scholar 

  40. Sherwin BB, Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008;29(1):88–113.

    Article  CAS  PubMed  Google Scholar 

  41. Epperson CN, Amin Z, Ruparel K, Gur R, Loughead J. Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology. 2012;37(3):372–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the department of radiology at the Second Affiliated Hospital of Shandong First Medical University for continuous support.

Funding

The present study was supported by grants from the Academic Promotion Programme of Shandong First Medical University (No. 2019QL017) and Science and Technology Planning Project of Taian (No. 2018NS0238).

Author information

Author notes

  1. Min Liu and Hui Yang are co-first authors

Authors and Affiliations

  1. Department of Radiology, The Second Affiliated Hospital of Shandong First Medical University, No.366 Taishan Street, Tai’an, Shandong, China

    Min Liu, Hui Yang, Jian Qin, Qianqian Yao, Guihua Yang & Jiang Li

Authors
  1. Min Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jian Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qianqian Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guihua Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ML: Writing-original draft preparation. HY: Conceptualization, writing-reviewing and editing. JQ: Formal analysis, methodology. QY: Visualization, resources. GY: Formal analysis, data curation, software. JL: Conceptualization, study design and interpretation of data. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jiang Li.

Ethics declarations

Ethics approval and consent to participate

The study was performed in accordance with the Declaration of Helsinki and approved by the ethics review committee of the second affiliated hospital of shandong first medical university (No. 2004018). Informed written consent was obtained from each participant.

Consent to publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, M., Yang, H., Qin, J. et al. Changes in the regional homogeneity of resting-state magnetic resonance imaging in perimenopausal women. BMC Women's Health 21, 39 (2021). https://doi.org/10.1186/s12905-020-01171-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-020-01171-7

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us